Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault
Toxins: Established and Emergent ThreatsChapter 19Toxins: Established and EmergentThreatsPatrick Williams, MS*; Scott Willens, DVM, PhD † ; Jaime Anderson, DVM, PhD ‡ ; Michael Adler, PhD § ;a n d Corey J. Hilmas, MD, PhD ¥IntroductionNature of the ThreatEstablished ThreatsEmergent ThreatsToxinsPalytoxinTetrodotoxin and SaxitoxinBrevetoxinBatrachotoxinSummary* Research Biologist, Department of Neurobehavioral Toxicology, US Army Medical Research Institute of Chemical Defense, 3100 Ricketts Point Road,Aberdeen Proving Ground, Maryland 21010†Major, Veterinary Corps, US Army; Chief of Department of Neurobehavioral Toxicology, Analytical Toxicology Division, US Army Medical ResearchInstitute of Chemical Defense, 3100 Ricketts Point Road, Aberdeen Proving Ground, Maryland 21010‡ Division Chief, Analytical Toxicology Division, Department of Neurobehavioral Toxicology, US Army Medical Research Institute of Chemical Defense,3100 Ricketts Point Road, Aberdeen Proving Ground, Maryland 21010§Research Pharmacologist, Neurobehavioral Toxicology, Department of Neurobehavioral Toxicology, US Army Medical Research Institute of ChemicalDefense, 3100 Ricketts Point Road, Aberdeen Proving Ground, Maryland 21010¥Research Physiologist and Pharmacologist, Analytical Toxicology Division, Department of Neurobehavioral Toxicology, US Army Medical ResearchInstitute of Chemical Defense, 3100 Ricketts Point Road, Aberdeen Proving Ground, Maryland 21010613
Medical Aspects of Chemical WarfareINTRODUCTIONIn its definition of “toxin,” the 1993 ChemicalWeapons Convention includes “any chemical whichthrough its chemical action on life processes can causedeath, temporary incapacitation or permanent harm tohumans or animals,” regardless of its origin or methodof production. 1 Because there is no consensus on theinclusion criterion for toxins, international law regardsa wide range of biological and chemical substancesas toxins.An array of toxins exists among the species of allkingdoms (Table 19-1). Many of these toxins have wellcharacterizedand therapeutic effects and have beenemployed as medical treatments and scientific tools.However, many can have nefarious applications, especiallywhen used outside of their therapeutic indices.The wide spectrum of toxins includes the followingthree categories: 1) bacterial toxins (eg, botulinumneurotoxin and staphylococcal enterotoxin), whichare high-molecular–weight proteins produced inlarge quantity by industrial microbiological methods;2) snake poisons, insect venoms, plant proteins, andmarine algae, which are either naturally occurringor chemically synthesized (eg, curare, batrachotoxin[BTX], and ricin); and 3) small molecules, such aspotassium fluoroacetate, which are synthesized bychemical processes and produced by living organisms.This chapter focuses on the second toxin group.Nature of the ThreatAn attack involving a mass-casualty–producingweapon, whether biological or chemical, can no longerbe anticipated only from hostile states. Some nonstateand terrorist entities have limited moral or social reservationsabout attacking civilian populations with theintent of causing large numbers of casualties. Agentsconsidered “classical” chemical or biological weapons,such as mustard gas, organophosphorous nerveagents, botulinum toxin, and anthrax, threaten thehealth and safety of civilian and military populations.Throughout the 20th century, numerous countries havedeveloped and stockpiled chemical and biologicalagents. Changes in the geopolitical climate over thelast 30 years have made it possible for these weaponsto fall into terrorists’ hands.Any toxin is a putative, mass-casualty–producingweapon, and to objectively estimate the threats theymight pose, toxins must be evaluated against severalcriteria. First, the potential weapon agent must besuitably toxic. Groups who intend to injure or kill willnot waste time or limited resources on agents that areharmless irritants to humans. Marginally toxic compoundsmust be stockpiled in very large quantities(tons) to produce an effective weapon. Similarly, toxinsthat produce mild effects following intoxication, or effectsfor which there are readily available treatments orantitoxins, are less likely threats. Many toxins can bediscounted as potential candidates for weaponizationbased on this criterion alone.Second, the requirement to stockpile toxin suggeststhat terrorists must possess the storage capability tomaintain toxin potency and prevent toxin degradation.Unstable toxins with short half-lives or toxinsthat require special handling or storage conditions aretypically undesirable. Terrorists’ surroundings must beconsidered when assessing the stability of a potentialtoxin threat. For example, terrorists operating out ofcaves in mountains or tent encampments in the desertwill not possess the necessary equipment to handle andstore some toxins, but a small cell of college students ora state-sponsored group might have access to storagecontainers, a variety of solvents and acids to properlybuffer a toxin for long-term storage, temperature- andhumidity-controlled environments, and other specialhandling equipment.Third, for a toxin to create mass casualties, a sourceof the toxin must be readily available. It is unlikelythat terrorist groups would tend large snake farms, forexample, to harvest snake toxin for weaponization. Inaddition to other logistical challenges, such an undertakingwould be conspicuous and time consuming.However, if a commercial source of a particular toxinis available, the toxin becomes more attractive to a terroristorganization, particularly if the organization hasthe secure infrastructure available to acquire, purify,concentrate, and properly store toxin stocks. Manytoxins have been chemically synthesized and are commerciallyavailable to researchers and scientists. Commerciallyavailable toxins are typically sold in smallquantities for research purposes and are not cost prohibitive;however, some terrorist organizations are ableto purchase and store toxins for future weaponization,and the chemical reactions for the synthesis of manytoxins have been published in scientific literature andare therefore available to these organizations. Chemicalsynthesis begins with readily available, simple,and nontoxic compounds, which could be easily andinexpensively obtained from many scientific supplyhouses. In many cases, the requisite knowledge, skills,and apparatus to perform such synthesis are not trivial;however, for the well-equipped and skilled terrorist,there are no impediments to the synthesis and storageof very large quantities of toxin.A suitable delivery method must also be designed inadvance of bioweapon deployment for toxins to causea significant threat. While some toxins are lipid soluble614
- Page 585 and 586: Medical Aspects of Chemical Warfare
- Page 587 and 588: Medical Aspects of Chemical Warfare
- Page 589 and 590: Medical Aspects of Chemical Warfare
- Page 591 and 592: Medical Aspects of Chemical Warfare
- Page 593 and 594: Medical Aspects of Chemical Warfare
- Page 595 and 596: Medical Aspects of Chemical Warfare
- Page 597 and 598: Medical Aspects of Chemical Warfare
- Page 599 and 600: Medical Aspects of Chemical Warfare
- Page 601 and 602: Medical Aspects of Chemical Warfare
- Page 603 and 604: Medical Aspects of Chemical Warfare
- Page 605 and 606: Medical Aspects of Chemical Warfare
- Page 607 and 608: Medical Aspects of Chemical Warfare
- Page 609 and 610: Medical Aspects of Chemical Warfare
- Page 611 and 612: Medical Aspects of Chemical Warfare
- Page 613 and 614: Medical Aspects of Chemical Warfare
- Page 615 and 616: Medical Aspects of Chemical Warfare
- Page 617 and 618: Medical Aspects of Chemical Warfare
- Page 619 and 620: Medical Aspects of Chemical Warfare
- Page 621 and 622: Medical Aspects of Chemical Warfare
- Page 623 and 624: Medical Aspects of Chemical Warfare
- Page 625 and 626: Medical Aspects of Chemical Warfare
- Page 627 and 628: Medical Aspects of Chemical Warfare
- Page 629 and 630: Medical Aspects of Chemical Warfare
- Page 631 and 632: Medical Aspects of Chemical Warfare
- Page 633 and 634: Medical Aspects of Chemical Warfare
- Page 635: Medical Aspects of Chemical Warfare
- Page 639 and 640: Medical Aspects of Chemical Warfare
- Page 641 and 642: Medical Aspects of Chemical Warfare
- Page 643 and 644: Medical Aspects of Chemical Warfare
- Page 645 and 646: Medical Aspects of Chemical Warfare
- Page 647 and 648: Medical Aspects of Chemical Warfare
- Page 649 and 650: Medical Aspects of Chemical Warfare
- Page 651 and 652: Medical Aspects of Chemical Warfare
- Page 653 and 654: Medical Aspects of Chemical Warfare
- Page 655 and 656: Medical Aspects of Chemical Warfare
- Page 657 and 658: Medical Aspects of Chemical Warfare
- Page 659 and 660: Medical Aspects of Chemical Warfare
- Page 661 and 662: Medical Aspects of Chemical Warfare
- Page 663 and 664: Medical Aspects of Chemical Warfare
- Page 665 and 666: Medical Aspects of Chemical Warfare
- Page 667 and 668: Medical Aspects of Chemical Warfare
- Page 669 and 670: Medical Aspects of Chemical Warfare
- Page 671 and 672: Medical Aspects of Chemical Warfare
- Page 673 and 674: Medical Aspects of Chemical Warfare
- Page 675 and 676: Medical Aspects of Chemical Warfare
- Page 677 and 678: Medical Aspects of Chemical Warfare
- Page 679 and 680: Medical Aspects of Chemical Warfare
- Page 681 and 682: Medical Aspects of Chemical Warfare
- Page 683 and 684: Medical Aspects of Chemical Warfare
- Page 685 and 686: Medical Aspects of Chemical Warfare
<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong>INTRODUCTIONIn its definition <strong>of</strong> “toxin,” the 1993 <strong>Chemical</strong>Weapons Convention includes “any chemical whichthrough its chemical action on life processes can causedeath, temporary incapacitation or permanent harm tohumans or animals,” regardless <strong>of</strong> its origin or method<strong>of</strong> production. 1 Because there is no consensus on theinclusion criterion for toxins, international law regardsa wide range <strong>of</strong> biological and chemical substancesas toxins.An array <strong>of</strong> toxins exists among the species <strong>of</strong> allkingdoms (Table 19-1). Many <strong>of</strong> these toxins have wellcharacterizedand therapeutic effects and have beenemployed as medical treatments and scientific tools.However, many can have nefarious applications, especiallywhen used outside <strong>of</strong> their therapeutic indices.<strong>The</strong> wide spectrum <strong>of</strong> toxins includes the followingthree categories: 1) bacterial toxins (eg, botulinumneurotoxin and staphylococcal enterotoxin), whichare high-molecular–weight proteins produced inlarge quantity by industrial microbiological methods;2) snake poisons, insect venoms, plant proteins, andmarine algae, which are either naturally occurringor chemically synthesized (eg, curare, batrachotoxin[BTX], and ricin); and 3) small molecules, such aspotassium fluoroacetate, which are synthesized bychemical processes and produced by living organisms.This chapter focuses on the second toxin group.Nature <strong>of</strong> the ThreatAn attack involving a mass-casualty–producingweapon, whether biological or chemical, can no longerbe anticipated only from hostile states. Some nonstateand terrorist entities have limited moral or social reservationsabout attacking civilian populations with theintent <strong>of</strong> causing large numbers <strong>of</strong> casualties. Agentsconsidered “classical” chemical or biological weapons,such as mustard gas, organophosphorous nerveagents, botulinum toxin, and anthrax, threaten thehealth and safety <strong>of</strong> civilian and military populations.Throughout the 20th century, numerous countries havedeveloped and stockpiled chemical and biologicalagents. Changes in the geopolitical climate over thelast 30 years have made it possible for these weaponsto fall into terrorists’ hands.Any toxin is a putative, mass-casualty–producingweapon, and to objectively estimate the threats theymight pose, toxins must be evaluated against severalcriteria. First, the potential weapon agent must besuitably toxic. Groups who intend to injure or kill willnot waste time or limited resources on agents that areharmless irritants to humans. Marginally toxic compoundsmust be stockpiled in very large quantities(tons) to produce an effective weapon. Similarly, toxinsthat produce mild effects following intoxication, or effectsfor which there are readily available treatments orantitoxins, are less likely threats. Many toxins can bediscounted as potential candidates for weaponizationbased on this criterion alone.Second, the requirement to stockpile toxin suggeststhat terrorists must possess the storage capability tomaintain toxin potency and prevent toxin degradation.Unstable toxins with short half-lives or toxinsthat require special handling or storage conditions aretypically undesirable. Terrorists’ surroundings must beconsidered when assessing the stability <strong>of</strong> a potentialtoxin threat. For example, terrorists operating out <strong>of</strong>caves in mountains or tent encampments in the desertwill not possess the necessary equipment to handle andstore some toxins, but a small cell <strong>of</strong> college students ora state-sponsored group might have access to storagecontainers, a variety <strong>of</strong> solvents and acids to properlybuffer a toxin for long-term storage, temperature- andhumidity-controlled environments, and other specialhandling equipment.Third, for a toxin to create mass casualties, a source<strong>of</strong> the toxin must be readily available. It is unlikelythat terrorist groups would tend large snake farms, forexample, to harvest snake toxin for weaponization. Inaddition to other logistical challenges, such an undertakingwould be conspicuous and time consuming.However, if a commercial source <strong>of</strong> a particular toxinis available, the toxin becomes more attractive to a terroristorganization, particularly if the organization hasthe secure infrastructure available to acquire, purify,concentrate, and properly store toxin stocks. Manytoxins have been chemically synthesized and are commerciallyavailable to researchers and scientists. Commerciallyavailable toxins are typically sold in smallquantities for research purposes and are not cost prohibitive;however, some terrorist organizations are ableto purchase and store toxins for future weaponization,and the chemical reactions for the synthesis <strong>of</strong> manytoxins have been published in scientific literature andare therefore available to these organizations. <strong>Chemical</strong>synthesis begins with readily available, simple,and nontoxic compounds, which could be easily andinexpensively obtained from many scientific supplyhouses. In many cases, the requisite knowledge, skills,and apparatus to perform such synthesis are not trivial;however, for the well-equipped and skilled terrorist,there are no impediments to the synthesis and storage<strong>of</strong> very large quantities <strong>of</strong> toxin.A suitable delivery method must also be designed inadvance <strong>of</strong> bioweapon deployment for toxins to causea significant threat. While some toxins are lipid soluble614